Factors for increased morbidity and mortality in uremia: Hyperphosphatemia
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 24 (5) , 396-400
- https://doi.org/10.1016/j.semnephrol.2004.06.011
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dialysate calcium use in hemodialysis patientsKidney International, 2003
- Vascular CalcificationJournal of the American Society of Nephrology, 2003
- Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure ratsKidney International, 2003
- Bile acid binding to sevelamer HClKidney International, 2002
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- Phosphate kinetics during hemodialysis: Evidence for biphasic regulationKidney International, 2002
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*Nephrology Dialysis Transplantation, 1999
- Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysisKidney International, 1998